View Document Preview and Link Document Date: 2013-08-28 15:50:32 Open Document File Size: 1,23 MB Share Result on Facebook
Company M.D. / / Country United States / / Facility National Institute of Allergy / / IndustryTerm bioinformatics technologies / employed creative solutions / biotechnology / clinical trials networks / known as systems / sample processing / genomics technologies / clinical trial network / analytical tools / life‐saving pharmaceuticals / food / clinical trials infrastructure / genomic technologies / chemical threats / model systems / candidate vaccine products / ‐throughput technologies / manufacturing / therapies for hepatitis B / healthcare settings / Experimental technologies / research tools / research infrastructure / / MedicalCondition universal influenza / allergies / TB / HIV / parasitic infections / TB infections / common co‐infections / drug‐resistant tuberculosis / highly infectious pathogens / trachoma / infectious and immune‐mediated diseases / MDR TB / leishmaniasis / hepatitis C / infectious threats / hepatitis B / infectious causes / infectious and immune‐related diseases / avian influenza / Lyme disease / infectious pathogens / epidemics / illness / human immunodeficiency virus/acquired immunodeficiency syndrome / lupus / infections / Immune‐Mediated Diseases / infectious agents / influenza / endemic diseases / particular influenza / C virus infection / asthma / autoimmune diseases / Re‐emerging Diseases / H1N1 influenza / allergic diseases / immune dysfunction / disease / Neglected tropical diseases / extensively drug‐resistant tuberculosis / malaria / pneumonic plague / subsequent anthrax / multidrug‐resistant gonorrhea / diabetes / secondary infections / HCV / Allergy / lymphatic filariasis / early infection / diseases / acute and chronic hepatitis C / AIDS / infectious diseases / HIV/AIDS / dengue / tropical diseases / infection / particular diseases / anthrax / Immune‐mediated disorders / infectious disease / tuberculosis / / MedicalTreatment immunotherapies / antibiotics / chemotherapies / radiation / / Organization U.S. Department of Health and Human Services / National Institute of Health / World Health Organization / Infectious Diseases / NIAID Mission / Institute’s mission / National Institute of Allergy and Infectious Diseases / U.S. Food and Drug Administration / National Institute of Allergy / / Person Anthony S. Fauci / / Position Director Dear Colleagues / Director / Private / / Product levofloxacin / / Region West Nile / / Technology genomics / radiation / proteomics / bioinformatics / biotechnology / high‐throughput technologies / transcriptomics / transplantation / biopharmaceuticals / bioinformatics technologies / genomics technologies / lipidomics / metabolomics / / URL http / SocialTag 
NIAID Strategic Plan 2013